Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination ...
The Cool Down on MSN1d
Experts are concerned by the rising trend of a type of cancer in younger people: 'We're just scratching the surface'"Was their exposure part of it, or not?" Experts are concerned by the rising trend of a type of cancer in younger people: 'We ...
By analyzing ERBB2 mRNA expression data, researchers identified a group of HER2-negative patients with poor outcomes and potential markers of treatment resistance.
All nine patients showed a “successful anti-cancer immune response” after getting the vaccine. After an average of 34.7 months, they all remained cancer-free.
Dana-Farber Cancer Institute researchers will present important research studies during the 2025 ASCO Genitourinary (GU) ...
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
UFC president Dana White slammed American fighter Bryce Mitchell after the 30-year-old made several antisemitic, homophobic and transphobic comments during a podcast in which he also praised Adolf ...
Dana-Farber Cancer Institute, Boston, Massachusetts 02215 United States Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02215, United ...
This investigation was done in partnership with the Dana Farber Cancer Institute (DFCI). Columbia team uncovers key immune cells for treating relapsed acute Myeloid Leukemia. (Unsplash ...
Boston – Dana-Farber Cancer Institute researchers have identified factors that determine whether donor lymphocyte infusion (DLI), a standard therapy for patients with acute myeloid leukemia (AML ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback